Integrated Report

This corporate website is structured based on the Kirin Holdings value creation model.
The Kirin Group has converted the Integrated Report to the web in order to keep stakeholders up-to-date with the latest information.
Starting in January 2023, messages from executives of Kirin Holdings will be made available as needed as new content for the Integrated Report 2023.
In addition, the web pages of the Integrated Report (As of the end of June, 2022) contents have been converted to PDF format and compiled into the Integrated Report 2022.

The Kirin Group considers interactive communication with stakeholders to be important, and we hope that the Integrated Report will be of some help in this regard.


Read/Unread Status Icons
  • :Unread
  • :Read

Editorial Policy

The Kirin Group Vision 2027 (KV2027) adopted in fiscal 2019 sets the long-term management vision for the Group to become a global leader in CSV by creating value in the Food & Beverages and Pharmaceuticals domains.
The fiscal 2022 is the first year of new medium-term business plan (2022-204 MTBP), and this report describes the Kirin Group's intentions toward the achievement of 2022-2024 MTBP and the realization of KV2027.
We hope this report will help readers understand how the Kirin Group is using its CSV management to help address social issues through its business operations.


Kirin Holdings Company and the Kirin group companies


Kirin Holdings, Corporate Communications Department

Referenced Guidelines The integrated report was prepared with reference to the International Integrated Reporting Framework of the International Integrated Reporting Council (IIRC) and the Guidance for Integrated Corporate Disclosure and Company-Investor Dialogues for Collaborative Value Creation of the Ministry of Economy, Trade and Industry.

Cautionary statement regarding forward-looking statements

Statements in this report that are not historical facts are forward-looking statements

based on plans and expectations for the future. Accordingly, these forward-looking statements are subject to risks, uncertainties and other unpredictable factors, and may

differ considerably from actual results, business performance, and other future events.

In addition, forecasts of fiscal 2022 financial results were decided as of the disclosure of

financial results on February 14, 2022
Publications Available on Kirin’s Global Website
  • Environmental Report (Publication every June)
    The report details the Kirin Group’s annual environmental activities as well as unique business-driven initiatives. It presents the Kirin Group’s annual environmental activities and how it makes use of the unique characteristics of its businesses in environmental initiatives.
  • Consolidated Financial Statements( Publication every March 31)PDF:3.6MB
    Compiled in accordance with Article 24-1 of the Financial Instruments and Exchange Act of Japan, the report includes Kirin Holding’s financial statements along with an overview of its recent performance, business results, facilities, and operations.
    Period covered is fiscal 2021 (January 1, 2021 to December 31, 2021). Certain activities occurred in fiscal 2022.
  • Corporate Governance Report(Publication Every April)
    The report provides information on the Group’s approach to and system of corporate governance, maintained in compliance with the Corporate Governance Code of Japan.
    Period covered is fiscal 2021 (January 1, 2021 to December 31, 2021). Certain activities occurred in fiscal 2022.
  • 2022-2024 Medium-Term Business Plan webpage (Published in February 2022)
    The webpage features the 2022–2024 Medium-Term Business Plan, the Group’s first three-year plan focused on realizing the KV2027 long-term management vision.
  • ESG Data(Periodically updated)
    Kirin Holdings presents environment, society, and governance (ESG) data for recent years at the following website.
  • Data Book(Periodically updated)
    The book presents data about the Group’s business markets, pharmaceuticals development pipeline, and historical financial data.